Hepatitis C

Type: Keyphrase
Name: Hepatitis C
First reported Jul 25 2014 - Updated 10 hours ago - 2 reports

AIDS 2014: New Hope for Those Living With HCV/HIV Co-infection

News 2014News 2013News 2012News 2011News 2010News 2009News 2008News 2007News 2006News 2005-Older Dr. Henry Lik-Yuen ChanLife can be challenging for the 130 to 170 million people across the world who have the hepatitis C virus (HCV), a viral infection ... [Published BlackAIDS.org - 10 hours ago]
First reported Jul 25 2014 - Updated 17 hours ago - 2 reports

Trillium Health Holds Free Hepatitis C Clinic on Monroe Avenue

ROCHESTER, N.Y. -- Trillium Health offered free screenings Friday for National African American Hepatitis C Action Day.Hepatitis C is a serious and potentially deadly disease that disproportionately affects the African-American community.Health care providers, ... [Published YNN Rochester - 17 hours ago]
First reported Jul 25 2014 - Updated 19 hours ago - 2 reports

JULY 25: Second Annual African American Hepatitis C Awareness Day

Facebook Twitter Google + Email PrintFriday, July 25, 2014 is National African American Hepatitis C Action Day .The burden of hepatitis C (HCV) falls disproportionately on African Americans. At a 3% prevalence rate, African Americans have higher rates ... [Published Project Inform - 19 hours ago]
First reported Jul 24 2014 - Updated 19 hours ago - 6 reports

Doctors stress on hepatitis screening

Three doses of a vaccine can prevent hepatitis B. Yet, hepatitis remains largely ignored, leading to complications involving the liver.The stress is on the need for better awareness among people to get tested for hepatitis viruses and receive treatment ... [Published The Hindu - 19 hours ago]
First reported Jul 24 2014 - Updated 20 hours ago - 8 reports

Gilead's $1,000-a-pill hepatitis C drug breaks records, drives Q2 profit

With record-breaking revenue from its controversial hepatitis C drug, Gilead Sciences Inc. scored a second-quarter profit of nearly $3... ... [Published Nations Restaurant News - 20 hours ago]
First reported Jul 25 2014 - Updated 21 hours ago - 2 reports

AIDS 2014: AbbVie Hepatitis C Treatment Works Well for People on Methadone or Buprenorphine

People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a 97% cure rate, according ... [Published HIV and Hepatitis.com - 21 hours ago]
First reported Jul 25 2014 - Updated 22 hours ago - 2 reports

Vancouver street youth face alarmingly high risk of hepatitis C

CBC News Friday 25th July, 2014A drug user prepares heroin bought on the street at a supervised injection clinic in Vancouver. (Darryl Dyck/Canadian Press) Vancouver street youth face an alarmingly high risk of hepatitis C infection because of a high ... [Published Canada Standard - 22 hours ago]
First reported Jul 25 2014 - Updated Jul 25 2014 - 2 reports

WaterFire to help raise awareness of hepatitis C

PROVIDENCE, R.I. — This weekend's WaterFire will feature free hepatitis screenings to help raise awareness of a virus that affects an estimated 17,000 Rhode Islanders.Confidential screenings will be available on College Street during Saturday night's ... [Published Rock Hill Herald - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 6 reports

Study pinpoints hepatitis C risk for Vancouver street youth

The Globe and Mail Friday 25th July, 2014A 16-year-old boy injects heroin behind First United Church in Vancouver, April 20, 2011, before heading to the church sanctuary to sleep for the night. (JOHN LEHMANN/The Globe and Mail)Read more ... [Published Canada Standard - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 18 reports

A Re-Analysis Of Gilead After Q2 Results And The Early Idelalisib Approval

By DoctoRx:Gilead Sciences (NASDAQ: GILD ) reported yet another record quarter Wednesday after the bell, of $2.36 per share, which compares with $1.48 in Q1 and much lower in Q2 2013 (all data non-GAAP). Sales of Sovaldi for hepatitis C reached $3.5 B, ... [Published BioPortfolio - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 2 reports

New research findings may lead to better treatment plans for HIV patients coinfected with hepatitis C

Using a combination antiretroviral therapy to treat HIV patients coinfected with the hepatitis C virus (HCV) not only effectively treats HIV, but also results in reduced HCV replication, according to a multi-center study published this week in Science ... [Published Medical Xpress - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 4 reports

Gilead pill reaches $3.48B in quarterly sales

Despite criticism from insurers and lawmakers, Gilead Sciences said Wednesday its $1,000-a-day hepatitis C pill had improved on its record-setting debut as it reached $3.48 billion in sales last quarter.The drug, Sovaldi, can cure more than 90 percent ... [Published San Francisco Chronicle - Jul 24 2014]

Quotes

...a strategic action that will further enhance our long-term growth prospects," said Richard Gonzalez, chairman and chief executive of, AbbVie.   "Last month, we raised our 2014 earnings-per-share guidance, reflecting strong underlying business performance. We continue to expect positive trends for the second half of the year, as well as additional progress from our pipeline, including the expected US approval of our interferon-free HCV combination."
"If your loved ones might be at risk, they can speak with their medical provider to discuss appropriate testing options. We also encourage medical providers to reach outout to us to learn more about these recommendations. Providing these simple tests now can mean that they can have their patients avoid liver disease or even liver cancer later" he said
...responding as well to the DAAs as people who don't have HIV so unlike with interferon-based drugs, people living with HIV aren't at a disadvantage. "For the first time ever, people co-infected with HCV and HIV are no longer the poor cousins of hepatitis C mono-infected patients" Dr. Bhagani said

More Content

All (2528) | News (1987) | Reports (0) | Blogs (501) | Audio/Video (1) | Fact Sheets (12) | Press Releases (16)
sort by: Date | Relevance
AbbVie 2nd-qtr 2014 earnings beat forecasts [Published Pharma Letter - 1 hour ago]
Fear and loathing kills off drugs aid centre [Published Budapest Times - 3 hours ago]
WHO in the Western Pacific: Working towards a h... [Published WHO WPRO - 4 hours ago]
Coverage of the 2014 International AIDS Conference [Published HIV and Hepatitis.com - 8 hours ago]
Front Porch: Respond to that jury summons [Published HeraldNet - 9 hours ago]
Market Ignores AbbVie's Impressive Sales Due To... [Published Seeking Alpha - 10 hours ago]
Expert, Real-Time Advice on HCV [Published Physicians Weekly - 10 hours ago]
World Hepatitis Day, July 28, 2014 Hawaii Depar... [Published Insurance News Net - 10 hours ago]
Umoja Fest hepatitis screenings for World Hepat... [Published Seattle Gay News - 10 hours ago]
AIDS 2014: New Hope for Those Living With HCV/H... [Published BlackAIDS.org - 10 hours ago]
July 25 Is National African American Hepatitis ... [Published BlackAIDS.org - 10 hours ago]
MedMira adds three new rapid vertical flow test... [Published News-Medical.Net - 11 hours ago]
Expensive hepatitis drug challenges Medicaid pr... [Published News-Medical.Net - 11 hours ago]
Need To Rid Nigeria Of Drug Abuse [Published Leadership - 12 hours ago]
Healthnotes: Week of July 21 [Published Fairfield Sun - 12 hours ago]
Fundraiser slated to help Jared Stogner [Published Columbian Progress - 15 hours ago]
Nightly Business Report — July 25, 2014 [Published NBR.com - 16 hours ago]
Town Hall Forum to Address Hepatitis C [Published Afro American Newspaper - 16 hours ago]
Trillium Health Holds Free Hepatitis C Clinic o... [Published YNN Rochester - 17 hours ago]
The Drug That’s Forcing America’s Most Importan... [Published BioPortfolio - 17 hours ago]
WellCare Health Plans' (WCG) CEO Dave Gallitano... [Published Seeking Alpha - 18 hours ago]
News Scan for Jul 25, 2014 [Published Centre For Infectious Disease Research and Policy - 18 hours ago]
ECDC: Viral hepatitis in Europe [Published H5N1 - 18 hours ago]
Politicizing Gilead's Research And Development ... [Published Forbes.com - 19 hours ago]
JULY 25: Second Annual African American Hepatit... [Published Project Inform - 19 hours ago]
World: Statement of the UNODC Executive Directo... [Published ReliefWeb - Latest Updates - 19 hours ago]
Doctors stress on hepatitis screening [Published The Hindu - 19 hours ago]
Oral Hepatitis C Drugs Helping Patients Coinfec... [Published Medscape Women's Health - 19 hours ago]
World Hepatitis Day Highlights Global Scourge, ... [Published VOA News - 19 hours ago]
West Milton Woman Charged with Assaulting Polic... [Published WKEF ABC 22 - 20 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ECDC: Viral hepatitis in Europe [Published H5N1 - 18 hours ago]
With World Hepatitis Day coming on July 28, ECDC has published Viral hepatitis in Europe: undiagnosed and under-reported. Click through to download two reports. The summary:​Viral hepatitis affects millions of people across Europe without them even noticing ...
World: Statement of the UNODC Executive Directo... [Published ReliefWeb - Latest Updates - 19 hours ago]
Source: UN Office on Drugs and CrimeCountry: World Vienna, 25 July 2014 - Hepatitis C is a gravely debilitating disease and the growing cause of early death and severe liver disease among those who inject drugs. Of the 12.7 million people estimated to ...
New Hepatitis C Treatment: $84K Per Three-Month... [Published Crooks and Liars - 22 hours ago]
Since the federal government already provides so much of the R&D funding for pharmaceutical companies, and Big Pharma really exploits its stranglehold on certain drugs, maybe it's time to talk about either federal price ceilings, partial ownership ...
Q&A: The new $84,000 hepatitis C drug [Published Ezra Klein - Jul 25 2014]
What is hepatitis C? It’s a long-term liver illness that can last for life, and the most severe cases could lead to cirrhosis or liver cancer. Anywhere between 75 percent and 85 percent of people who contract the virus develop a chronic condition. ...
Why Sovaldi took off: Previous treatments were ... [Published Ezra Klein - Jul 25 2014]
  Gilead Sciences president and chief operating officer John Milligan (Victor J. Blue/Bloomberg) In a  story  Thursday, I dove into the societal implications of the new $84,000 hepatitis C treatment. There's one part I want to expand upon further: ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
GM Puts Engineers On Leave [Published Wall Street Journal What's News - Apr 10 2014]
1

Press Releases

sort by: Date | Relevance
U.S. FDA has granted Priority Review for OLYSIO... [Published GlobeNewswire: Advertising News - Jul 15 2014]
European Medicines Agency Validates Marketing A... [Published Financial Services - Jun 17 2014]
OraSure Technologies Announces New Co-Promotion... [Published GlobeNewswire: Advertising News - Jun 11 2014]
OLYSIO™ available soon in all Nordic countries ... [Published GlobeNewswire: Acquisitions News - Jun 10 2014]
OraSure Technologies Announces Rapid HCV Testin... [Published GlobeNewswire: Acquisitions News - May 19 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.